Imexpharm Corporation reported earnings results for the second quarter and six months ended June 30, 2022. For the second quarter, the company reported revenue was VND 354,451.56 million compared to VND 317,424.2 million a year ago. Net income was VND 46,612.12 million compared to VND 49,324.5 million a year ago. Basic earnings per share from continuing operations was VND 615 compared to VND 651 a year ago.
For the six months, revenue was VND 668,696.76 million compared to VND 613,861.22 million a year ago. Net income was VND 99,213.42 million compared to VND 91,180 million a year ago. Basic earnings per share from continuing operations was VND 1,310 compared to VND 1,266 a year ago.